Cargando…

Low expression of ZHX1 and ZHX2 impacts on the prognosis of chronic lymphocytic leukemia

Experimental evidence points to the role of Zinc fingers and homeoboxes protein 1 and 2 (ZHX1 and ZHX2) in the development and progression of several types of cancer, including hematological malignancies. Here, we determined whether the altered expression of ZHX1 and ZHX2 has clinical implications i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maciel, Natália Ioseph Gladistone, Filiú-Braga, Luma Dayane Carvalho, Neves, Francisco Assis Rocha, Rego, Eduardo Magalhaes, Lucena-Araujo, Antonio Roberto, Saldanha-Araujo, Felipe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863484/ https://www.ncbi.nlm.nih.gov/pubmed/33541423 http://dx.doi.org/10.1186/s40364-021-00263-2

Ejemplares similares

ZHX2 in health and disease
por: Li, Na, et al.
Publicado: (2022)

Low expression of ZHX3 is associated with progression and poor prognosis in colorectal cancer
por: Cai, Zhai, et al.
Publicado: (2023)

ZHX1 Promotes the Proliferation, Migration and Invasion of Cholangiocarcinoma Cells
por: Kwon, Ryuk-Jun, et al.
Publicado: (2016)

Upregulation of ZHX2 predicts poor prognosis and is correlated with immune infiltration in gastric cancer
por: Cheng, Anqi, et al.
Publicado: (2021)

The Inflammatory Status of Soluble Microenvironment Influences the Capacity of Melanoma Cells to Control T-Cell Responses
por: Bogéa, Gabriela Muller Reche, et al.
Publicado: (2022)

USP13 promotes deubiquitination of ZHX2 and tumorigenesis in kidney cancer
por: Xie, Haibiao, et al.
Publicado: (2022)

ZHX2 is a repressor of α-fetoprotein expression in human hepatoma cell lines
por: Shen, H, et al.
Publicado: (2008)

Transcription factor Zhx2 restricts NK cell maturation and suppresses their antitumor immunity
por: Tan, Siyu, et al.
Publicado: (2021)

ZHX2 inhibits thyroid cancer metastasis through transcriptional inhibition of S100A14
por: Zhang, Yankun, et al.
Publicado: (2022)

ZHX2 promotes HIF1α oncogenic signaling in triple-negative breast cancer
por: Fang, Wentong, et al.
Publicado: (2021)

Attenuated ZHX3 expression is predictive of poor outcome for liver cancer: Indication for personalized therapy
por: You, Yanjie, et al.
Publicado: (2022)

Zhx2 maintains islet β-cell mass and function by transcriptionally regulating Pax6
por: Ding, Lu, et al.
Publicado: (2023)

ZHX2 deficiency enriches hybrid MET cells through regulating E-cadherin expression
por: He, Yan, et al.
Publicado: (2023)

Assessment of the Immunosuppressive Potential of INF-γ Licensed Adipose Mesenchymal Stem Cells, Their Secretome and Extracellular Vesicles
por: Serejo, Teresa Raquel Tavares, et al.
Publicado: (2019)

ZHX1 Inhibits Gastric Cancer Cell Growth through Inducing Cell-Cycle Arrest and Apoptosis
por: Ma, Xingjie, et al.
Publicado: (2016)

Loss of the transcription repressor ZHX3 induces senescence-associated gene expression and mitochondrial-nucleolar activation
por: Igata, Tomoka, et al.
Publicado: (2022)

ZHX2 emerges as a negative regulator of mitochondrial oxidative phosphorylation during acute liver injury
por: Zhang, Yankun, et al.
Publicado: (2023)

Novel structural features in two ZHX homeodomains derived from a systematic study of single and multiple domains
por: Bird, Louise E, et al.
Publicado: (2010)

Tumor suppressor ZHX2 inhibits NAFLD–HCC progression via blocking LPL-mediated lipid uptake
por: Wu, Zhuanchang, et al.
Publicado: (2019)

Attenuated ZHX3 expression serves as a potential biomarker that predicts poor clinical outcomes in breast cancer patients
por: You, Yanjie, et al.
Publicado: (2019)

ZHX2 mediates proteasome inhibitor resistance via regulating nuclear translocation of NF‐κB in multiple myeloma
por: Jiang, Jifeng, et al.
Publicado: (2020)

Novel VHL substrate targets SFMBT1 and ZHX2 may be important prognostic predictors in patients with ccRCC
por: Chen, Yufeng, et al.
Publicado: (2021)

ZHX2 enhances the cytotoxicity of chemotherapeutic drugs in liver tumor cells by repressing MDR1 via interfering with NF-YA
por: Ma, Hongxin, et al.
Publicado: (2014)

Blocking lncRNA MALAT1/miR-199a/ZHX1 Axis Inhibits Glioblastoma Proliferation and Progression
por: Liao, Keman, et al.
Publicado: (2019)

ZHX3 promotes the progression of urothelial carcinoma of the bladder via repressing of RGS2 and is a novel substrate of TRIM21
por: Deng, Minhua, et al.
Publicado: (2021)

Cooperative regulation of Zhx1 and hnRNPA1 drives the cardiac progenitor-specific transcriptional activation during cardiomyocyte differentiation
por: Chen, Yang, et al.
Publicado: (2023)

ZHX2 restricts hepatocellular carcinoma by suppressing stem cell-like traits through KDM2A-mediated H3K36 demethylation
por: Lin, Qinghai, et al.
Publicado: (2020)

LncRNA LINC01140 Inhibits Glioma Cell Migration and Invasion via Modulation of miR-199a-3p/ZHX1 Axis
por: Xin, Yanchao, et al.
Publicado: (2020)

ZHX2 drives cell growth and migration via activating MEK/ERK signal and induces Sunitinib resistance by regulating the autophagy in clear cell Renal Cell Carcinoma
por: Zhu, Liangsong, et al.
Publicado: (2020)

HNRNPD interacts with ZHX2 regulating the vasculogenic mimicry formation of glioma cells via linc00707/miR-651-3p/SP2 axis
por: Yu, Sifei, et al.
Publicado: (2021)

Correction: ZHX2 drives cell growth and migration via activating MEK/ERK signal and induces Sunitinib resistance by regulating the autophagy in clear cell Renal Cell Carcinoma
por: Zhu, Liangsong, et al.
Publicado: (2021)

Characterization of circSEC11A as a novel regulator of Iodine-125 radioactive seed-induced anticancer effects in hepatocellular carcinoma via targeting ZHX2/GADD34 axis
por: Li, Dong, et al.
Publicado: (2023)

The expression of the CD56 antigen is associated with poor prognosis in patients with acute myeloid leukemia
por: Rego, Eduardo Magalhães
Publicado: (2011)

Differential peripheral blood mononuclear cell reactivity against SARS-CoV-2 proteins in naïve and previously infected subjects following COVID-19 vaccination
por: Bispo, Elizabete Cristina Iseke, et al.
Publicado: (2022)

LL-37 boosts immunosuppressive function of placenta-derived mesenchymal stromal cells
por: Oliveira-Bravo, Martha, et al.
Publicado: (2016)

Prognosis Factors in Chronic Lymphocytic Leukemia
por: Ivanescu, AM, et al.
Publicado: (2012)

Comparison of microRNA expression in high-count monoclonal B-cell lymphocytosis and Binet A chronic lymphocytic leukemia
por: Furtado, Felipe Magalhães, et al.
Publicado: (2017)

GVHD-derived plasma as a priming strategy of mesenchymal stem cells
por: Silva-Carvalho, Amandda Évelin, et al.
Publicado: (2020)

Metabolites of endophytic fungi isolated from leaves of Bauhinia variegata exhibit antioxidant activity and agonist activity on peroxisome proliferator-activated receptors α, β/δ and γ
por: Mesquita, Pedro Góes, et al.
Publicado: (2022)

Mannose-binding lectin 2 (MBL2) gene polymorphisms do not influence frequency of infections in chronic lymphocytic leukemia patients
por: Holanda, Katarina, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_u31f3ntosdfmhncj51q5oa27em